Last edition
News about "allergic conditions"
Eli Lilly to Acquire Merida Biosciences in Deal Valued at Up to USD 2.875 Billion
Eli Lilly will acquire Merida Biosciences for up to $2.875 billion to advance precision therapies targeting disease-causing autoantibodies.
Allergic Conditions | 01/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members